Dexrazoxane Intravenous and Metformin and repaglinide
Determining the interaction of Dexrazoxane Intravenous and Metformin and repaglinide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: metformin / repaglinide
Brand name: PrandiMet
Synonyms: Repaglinide and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Metformin and saxagliptin
- Dexrazoxane Intravenous-Metformin and sitagliptin
- Dexrazoxane Intravenous-Metformin Extended-Release Tablets
- Dexrazoxane Intravenous-Metformin Hydrochloride
- Dexrazoxane Intravenous-Metformin Oral Solution
- Dexrazoxane Intravenous-Metformin Tablets
- Metformin and repaglinide-Dextenza Insert
- Metformin and repaglinide-Dextenza intraocular
- Metformin and repaglinide-Dextran 40
- Metformin and repaglinide-Dextran 70 6% in 5% Dextrose high molecular weight
- Metformin and repaglinide-Dextran 75
- Metformin and repaglinide-Dextran high molecular weight